Adverse Drug Reactions Programme - On Demand
- $345.00 incl. GST for PSNZ members
- $550.00 incl. GST for NZHPA members
- $550.00 incl. GST for non-members
About the product
BACK BY POPULAR DEMAND, WE'RE EXCITED TO BE RUNNING OUR 2020 LIVE PROGRAMME "ADVERSE DRUG REACTIONS" ON DEMAND IN 2021.
About this learning module;
This learning consists of 4 modules. Each module has a 2-hour webinar, supplementary readings and associated assessments.
The learning modules covered are;
- Adverse Drug Reactions
- Drug Interactions
- Drug Hypersensitivity and Drug Allergy
- ADR reporting and Pharmacovigilance
Click here for detailed learning objectives.
This learning activity has been accredited by PSNZ Education (Professional Development and Training) for 12 hours of professional learning and is suitable for inclusion in a pharmacist’s records for Continuing Professional Development (CPD) purposes.
WHAT PEOPLE SAID ABOUT THE LIVE PROGRAMME:
" I found David Woods style very easy to listen to. It was not boring at all and even the more complicated portions were covered well. There was a good mix of self-study/reading and listening and watching"
" Webinars were great - good length and topics well differentiated. Quizzes and final case study were a good way of consolidating the learning for each topic."
" I have gained a better understanding of the mechanisms of interactions. I also gained an understanding of how to report an adverse reaction which I did not realise we could do."
PRESENTED BY: DAVID WOODS (MPHARM, FNZHPA, FPS, FRPS, FRGS)
David Woods is an independent pharmaceutical consultant with extensive experience in pharmacy, education, medicines information and clinical pharmacy practice. He was previously involved with the postgraduate program at the School of Pharmacy, University of Otago and participated in the medicines information papers since their inception.
As a contractor, David has worked with BPAC on various projects including management of the initial development and publication of the New Zealand Formulary. David works as an adviser and educator on rational medicine use and clinical pharmacy in several other countries including Oman, Kazakhstan, Brazil and Lithuania. He is currently involved with pharmacovigilance research at BPAC and the New Zealand Pharmacovigilance Centre and works in practice as a clinical pharmacist in a multidisciplinary pain clinic. David also has an interest in drug allergy and clinical decision support and developed the prototype data set for implementation into electronic prescribing systems in New Zealand. He is involved with research projects to identify the propensity for adverse events from electronic medical records.